Rockwell Medical (RMTI) Tops Q1 EPS by 3c, provides guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $7.99 --0%
Revenue Growth %: +14.9%
Financial Fact:
Net Income (Loss): -4.56M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.9%
Financial Fact:
Net Income (Loss): -4.56M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $18.9 million versus the consensus estimate of $19.14 million.
GUIDANCE:
Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $67.424 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon and Corning reach multi-billion fiber supply deal
- KeyBanc Reiterates Overweight Rating on Jacobs Engineering Group Inc. (J)
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
